Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease

Lupus

Volumn 18, Issue 3, 2009, Pages 223-229

  Souza, A ^a   da Silva, L M ^a   Oliveira, F R ^a   Roselino, A M F ^a   Louzada Junior, Paulo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti chromatin; Anti nucleosome; Cutaneous lupus; SLEDAI; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CHROMATIN ANTIBODY; NUCLEOSOME ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CHILD; CHROMATIN; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NUCLEOSOMES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 60449092070     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308096255     Document Type: Article

References (37)

1. Goodfiel MJD, Jones SK, Veale DJ. The connective tissue diseases. In: T Burns, S Brethnach, N Cox, C Griffiths, (eds) Rook's textbook of dermatology. 7th ed. Blackwell; 2004. p. 1-70.
2. Meller S, Winterberg F, Gilliet M, et al. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005; 52: 1504-1516.
3. Kunh A, Herrmann M, Kleber S, et al. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 2006; 54: 939-950.
4. Reefman E, De Jong MC, Kuiper H, et al. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus. Arthritis Res Ther 2006; 8: R156.
5. Baima B, Sticherling M. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 2001; 144: 958-966.
6. Merovach D, Zhou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 1998; 188: 387-392.
7. Radic M, Marion T, Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J Immunol 2004; 172: 6692-6700.
8. Stollar BD, Stephenson F. Apoptosis and nucleosomes. Lupus 2002; 11: 787-789.
9. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: A major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 1367-1381.
10. Berden JH. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens 1999; 8: 299-306.
11. Grootscholten C, Dieker JW, Mcgrath FD, et al. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Ann Rheum Dis 2007; 66: 693-696.
12. Hochberg MC. Updating the American College of Rheumatology Revised Criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725 (letter).
13. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-813.
14. Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Scand J Rheumatol 2007; 36: 442-447.
15. Gómez-Puerta JA, Burlingame RW, Cervera R. Antichromatin (antinucleosome) antibodies. Lupus 2006; 15: 408-411.
16. Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 2004; 43: 2002-2004.
17. Ghillani-Dalbin P, Amoura Z, Cacoub P, et al. Testing for anti-nucleosome antibodies in daily practice: A monocentric evaluation in 1696 patients. Lúpus 2003; 12: 833-837.
18. Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995; 38: 1485-1491.
19. Burlingame RW. The clinical utility of anti-histone antibodies: autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus. Clin Lab Med 1997; 17: 367-378.
20. Rahman A, Hiepe F. Anti-DNA antibodies-overview of assays and clinical correlations. Lupus 2002; 11: 770-773.
21. Servais G, Daens S, Guillaume MP, Cumps J, Duchateau J, Peretz A. Diagnostic specificities and sensitivities of anti-dsDNA, anti-membrane DNA and anti-nucleosome autoantibodies. Scan J Clin Lab Invest 2001; 61: 61-67.
22. Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR. Cutaneous lupus erythematosus without systemic lupus erythematosus: Clinical and laboratory features. Semin Arthritis Rheum 1992; 21: 221-226.
23. Tebbe B, Mansmann U, Wollina U, et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. a multicenter study on 296 patients. Acta Derm Venereol 1997; 77: 305-308.
24. Tebbe B, Orfanos CE. Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms. Hautarzt 1992; 43: 130-133.
25. Amoura Z, Koutouzov S, Chabre H, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases. Arthritis Rheum 2000; 43: 76-84.
26. Julkunen H, Salonen EM, Walle TK, Miettinen A. Anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus. Scand J Rheumatol 2005; 2: 122-124.
27. Ng KP, Masson JJ, Rahman A, Isenberg DA. Association of anti-nucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum 2006; 55: 900-904.
28. Su Y, Jia RL, Han L, Li ZG. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus. Clin Immunol 2007; 122: 115-120.
29. Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL, Joh T. LJP 394 Investigator Consortium. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1129-1137.
30. Isenberg D. Anti-dsDNA antibodies: Still a useful criterion for patients with systemic lupus erythematosus. Lupus 2004; 13: 881-885.
31. Min DJ, Kim SJ, Park SH, et al. Anti-nucleosome antibody: Significance in lupus patients lacking anti-double stranded-DNA antibody. Clin Exp Rheumatol 2002; 20: 13-18.
32. Adrianzén-Gutiérrez OA, Koutouzov S, Mota RMS, et al. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: A prospective study comparing anti-nucleosome with anti-dsDNA antibodies. J Rheumatol 2006; 3: 1538-1544.
33. Saisoong S, Eiam-Ong S, Hanvivatvong O. Correlations between anti-nucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Clin Exp Rheumatol 2006; 24: 51-58.
34. Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol 2000; 12: 369-373.
35. Amoura Z, Chabre H, Koutouzov S, et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or anti-histone antibodies in serum of MRL-Mp Ipr/Ipr and +/+mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994; 37: 568-577.
36. Suenaga R, Mitamura K, Abdou NI. Isolation of anti-nucleosome antibodies from the plasma of lupus nephritis patients. Clin Rheumatol 1998; 17: 189-194.
37. Van Bavel CC, Van Der Vlag J, Berden JH. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 2007; 71: 664-672.